HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suppression of Her2/Neu mammary tumor development in mda-7/IL-24 transgenic mice.

Abstract
Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24) encodes a tumor suppressor gene implicated in the growth of various tumor types including breast cancer. We previously demonstrated that recombinant adenovirus-mediated mda-7/IL-24 expression in the mammary glands of carcinogen-treated (methylnitrosourea, MNU) rats suppressed mammary tumor development. Since most MNU-induced tumors in rats contain activating mutations in Ha-ras, which arenot frequently detected in humans, we presently examined the effect of MDA-7/IL-24 on Her2/Neu-induced mammary tumors, in which the RAS pathway is induced. We generated tet-inducible MDA-7/IL-24 transgenic mice and crossed them with Her2/Neu transgenic mice. Triple compound transgenic mice treated with doxycycline exhibited a strong inhibition of tumor development, demonstrating tumor suppressor activity by MDA-7/IL-24 in immune-competent mice. MDA-7/IL-24 induction also inhibited growth of tumors generated following injection of Her2/Neu tumor cells isolated from triple compound transgenic mice that had not been treated with doxycycline, into the mammary fat pads of isogenic FVB mice. Despite initial growth suppression, tumors in triple compound transgenic mice lost mda-7/IL-24 expression and grew, albeit after longer latency, indicating that continuous presence of this cytokine within tumor microenvironment is crucial to sustain tumor inhibitory activity. Mechanistically, MDA-7/IL-24 exerted its tumor suppression effect on HER2+ breast cancer cells, at least in part, through PERP, a member of PMP-22 family with growth arrest and apoptosis-inducing capacity. Overall, our results establish mda-7/IL-24 as a suppressor of mammary tumor development and provide a rationale for using this cytokine in the prevention/treatment of human breast cancer.
AuthorsYou-Jun Li, Guodong Liu, Lei Xia, Xiao Xiao, Jeff C Liu, Mitchell E Menezes, Swadesh K Das, Luni Emdad, Devanand Sarkar, Paul B Fisher, Michael C Archer, Eldad Zacksenhaus, Yaacov Ben-David
JournalOncotarget (Oncotarget) Vol. 6 Issue 35 Pg. 36943-54 (Nov 10 2015) ISSN: 1949-2553 [Electronic] United States
PMID26460950 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukins
  • Membrane Proteins
  • Perp protein, mouse
  • RNA, Messenger
  • interleukin-24
  • Erbb2 protein, mouse
  • Receptor, ErbB-2
Topics
  • Animals
  • Apoptosis
  • Cell Transformation, Neoplastic (genetics)
  • Disease Models, Animal
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immunoenzyme Techniques
  • Interleukins (physiology)
  • Mammary Neoplasms, Animal (genetics, pathology)
  • Mammary Tumor Virus, Mouse (genetics)
  • Membrane Proteins (genetics)
  • Mice
  • Mice, Transgenic
  • RNA, Messenger (genetics)
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Receptor, ErbB-2 (physiology)
  • Reverse Transcriptase Polymerase Chain Reaction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: